文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

首选语言介导种族和民族与COVID-19危重患者就诊延迟之间的关联

Preferred Language Mediates Association Between Race, Ethnicity, and Delayed Presentation in Critically Ill Patients With COVID-19.
PubMed 文献 · Crit Care Explor · 2023-06-14
一句话结论在COVID-19危重患者中,首选非英语语言介导了种族和民族与就诊延迟之间63%的关联;保险状态、社会脆弱性和距医院距离不在因果路径上。

这项多中心回顾性队列研究纳入2020年马萨诸塞州三家医院连续收入ICU的442例COVID-19成人患者,采用因果中介分析评估首选语言、保险状态和社区特征等潜在中介因素。非西班牙裔白人患者较少数族裔患者从症状出现到入院早1.67天(95%CI 0.71-2.63,p<0.01);首选非英语语言与入院延迟1.29天相关(95%CI 0.40-2.18,p<0.01)。首选语言介导了种族和民族与从症状出现到入院天数之间总效应的63%(p=0.02);保险状态、社会脆弱性和距医院距离不在因果路径上。作者认为进一步研究首选语言在种族和民族差异中的作用可能有助于找到实现公平医疗的有效解决方案,但结果受可能的对撞分层偏倚限制。

要点

  • 在442例COVID-19 ICU患者中,非西班牙裔白人患者从症状出现到入院比少数族裔患者早1.67天(95%CI 0.71-2.63,p<0.01)。
  • 首选非英语语言与入院延迟1.29天相关(95%CI 0.40-2.18,p<0.01)。
  • 首选语言介导了种族和民族与从症状出现到入院天数之间总效应的63%(p=0.02)。
  • 保险状态、社会脆弱性和距医院距离不在种族和民族与入院延迟之间的因果路径上。
  • 作者认为进一步研究首选语言在种族和民族差异中的作用可能有助于找到实现公平医疗的有效解决方案。

适用人群与场景

  • 2020年连续收入马萨诸塞州三家医院ICU的COVID-19成人患者,共442例,其中非西班牙裔白人患者157/442(36%)。

研究设计与关键结果

  • 研究设计为多中心、回顾性队列研究,纳入2020年马萨诸塞州三家医院连续收入ICU的442例COVID-19成人患者,采用因果中介分析评估首选语言、保险状态和社区特征等潜在中介因素。
  • 非西班牙裔白人患者较少数族裔患者更可能以英语为首选语言(78% vs. 13%),更少无保险或保险不足(1% vs. 28%),居住在社會脆弱性指数(SVI)更低的社区(SVI百分位59[28] vs. 74[21]),但合并症更多(Charlson合并症指数4.6[2.5] vs. 3.0[2.5]),年龄更大(70[13.2] vs. 58[15.1]岁)。
  • 从症状出现起,非西班牙裔白人患者比少数族裔患者早入院1.67天(95%CI 0.71-2.63,p<0.01)。
  • 首选非英语语言与入院延迟1.29天相关(95%CI 0.40-2.18,p<0.01)。
  • 首选语言介导了种族和民族与从症状出现到入院天数之间总效应的63%(p=0.02)。
  • 保险状态、社会脆弱性和距医院距离不在种族和民族与入院延迟之间的因果路径上。

证据类型、等级与局限

  • 证据类型:多中心、回顾性队列研究。
  • 局限:原文报告结果受可能的对撞分层偏倚(collider stratification bias)限制。

对床旁实践的改变

  • 作者认为进一步研究首选语言在种族和民族差异中的作用可能有助于找到实现公平医疗的有效解决方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Which social factors explain racial and ethnic disparities in COVID-19 access to care and outcomes remain unclear.

OBJECTIVES: We hypothesized that preferred language mediates the association between race, ethnicity and delays to care.

DESIGN SETTING AND PARTICIPANTS: Multicenter, retrospective cohort study of adults with COVID-19 consecutively admitted to the ICU in three Massachusetts hospitals in 2020.

MAIN OUTCOME AND MEASURES: Causal mediation analysis was performed to evaluate potential mediators including preferred language, insurance status, and neighborhood characteristics.

RESULTS: Non-Hispanic White (NHW) patients (157/442, 36%) were more likely to speak English as their preferred language (78% vs. 13%), were less likely to be un- or under-insured (1% vs. 28%), lived in neighborhoods with lower social vulnerability index (SVI) than patients from racial and ethnic minority groups (SVI percentile 59 [28] vs. 74 [21]) but had more comorbidities (Charlson comorbidity index 4.6 [2.5] vs. 3.0 [2.5]), and were older (70 [13.2] vs. 58 [15.1] years). From symptom onset, NHW patients were admitted 1.67 [0.71-2.63] days earlier than patients from racial and ethnic minority groups (p < 0.01). Non-English preferred language was associated with delay to admission of 1.29 [0.40-2.18] days (p < 0.01). Preferred language mediated 63% of the total effect (p = 0.02) between race, ethnicity and days from symptom onset to hospital admission. Insurance status, social vulnerability, and distance to the hospital were not on the causal pathway between race, ethnicity and delay to admission.

CONCLUSIONS AND RELEVANCE: Preferred language mediates the association between race, ethnicity and delays to presentation for critically ill patients with COVID-19, although our results are limited by possible collider stratification bias. Effective COVID-19 treatments require early diagnosis, and delays are associated with increased mortality. Further research on the role preferred language plays in racial and ethnic disparities may identify effective solutions for equitable care.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Kelly MS, Mohammed A, Okin D, et al. Preferred Language Mediates Association Between Race, Ethnicity, and Delayed Presentation in Critically Ill Patients With COVID-19. Crit Care Explor. 2023. PMID: 37332365. doi:10.1097/CCE.0000000000000927

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。